1. Brücher K, Illarionov B, Held J, Tschan S, Kunfermann A, Pein MK, Bacher A, Gräwert T, Maes L, Mordmüller B, Fischer M, Kurz T.. (2012) α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation., 55 (14): [PMID:22731758] [10.1021/jm300652f] |
2. Konzuch S, Umeda T, Held J, Hähn S, Brücher K, Lienau C, Behrendt CT, Gräwert T, Bacher A, Illarionov B, Fischer M, Mordmüller B, Tanaka N, Kurz T.. (2014) Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC., 57 (21): [PMID:25254502] [10.1021/jm500850y] |
3. Wang X, Edwards RL, Ball H, Johnson C, Haymond A, Girma M, Manikkam M, Brothers RC, McKay KT, Arnett SD, Osbourn DM, Alvarez S, Boshoff HI, Meyers MJ, Couch RD, Odom John AR, Dowd CS.. (2018) MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria., 61 (19): [PMID:30192536] [10.1021/acs.jmedchem.8b01026] |
4. Courtens C, Risseeuw M, Caljon G, Cos P, Van Calenbergh S.. (2018) Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents., 9 (10): [PMID:30344904] [10.1021/acsmedchemlett.8b00223] |
5. Courtens C, Risseeuw M, Caljon G, Cos P, Martin A, Van Calenbergh S.. (2019) Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents., 29 (9): [PMID:30857749] [10.1016/j.bmcl.2019.03.008] |
6. Courtens C, Risseeuw M, Caljon G, Maes L, Cos P, Martin A, Van Calenbergh S.. (2019) Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents., 29 (10): [PMID:30879839] [10.1016/j.bmcl.2019.03.009] |
7. Lienau C, Gräwert T, Alves Avelar LA, Illarionov B, Held J, Knaab TC, Lungerich B, van Geelen L, Meier D, Geissler S, Cynis H, Riederer U, Buchholz M, Kalscheuer R, Bacher A, Mordmüller B, Fischer M, Kurz T.. (2019) Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity., 181 [PMID:31382119] [10.1016/j.ejmech.2019.07.058] |
8. Indorf P, Kubitza C, Scheidig AJ, Kunze T, Clement B.. (2020) Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates., 63 (12): [PMID:31790578] [10.1021/acs.jmedchem.9b01483] |
9. Kesharwani S, Sundriyal S.. (2021) Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective., 213 [PMID:33303239] [10.1016/j.ejmech.2020.113055] |